Redmile Group, LLC
SEC Form 4 insider trading activity
Redmile Group, LLC has filed 4 SEC Form 4 filings (13 transaction rows) across 4 companies, including ATTO, ATRA, FATE, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 8, 2026.
On the most recent filing, Redmile Group, LLC is listed as 10% Owner at Attovia Therapeutics, Inc. Inside the rolling window, Redmile Group, LLC reported 1 open-market purchase totaling $10.2M in ATTO and 3 open-market sales totaling $19.6M in ADCT. The largest disclosed transaction in the window is a sale of 5,163,997 ADCT shares on Apr 2, 2026, worth $16.9M.
Companies traded
Other insiders at ATTO
Insider Buying
$10.2M
reported purchases (SEC code P)
Insider Selling
$19.6M
reported sales (SEC code S)
Companies
4
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Redmile Group, LLC made?
Redmile Group, LLC has filed 4 SEC Form 4 filings (13 transaction rows) across 4 companies, including ATTO, ATRA, FATE since 2026.
Which companies does Redmile Group, LLC trade?
Redmile Group, LLC has filed SEC Form 4 disclosures for 4 companies, including ATTO, ATRA, FATE.
When was Redmile Group, LLC's most recent SEC Form 4 filing?
Redmile Group, LLC's most recent SEC Form 4 filing on Tracefour is dated Aug 8, 2026.
What is Redmile Group, LLC's total buy and sell value in the current window?
Inside the rolling retention window, Redmile Group, LLC bought $10.2M and sold $19.6M based on SEC Form 4 filings.
What was Redmile Group, LLC's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,163,997 ADCT shares on 2026-04-02, worth $16.9M, per SEC Form 4 filings.